Artelo biosciences to present at microcap rodeo's annual winter wonderland – best ideas virtual investor conference on february 22, 2023

Solana beach, ca / accesswire / february 15, 2023 / artelo biosciences, inc. (nasdaq:artl), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that it has been invited to present at microcap rodeo's third annual winter wonderland - best ideas virtual investor conference, which is being held virtually on february 21st - 24th, 2023. gregory d.
ARTL Ratings Summary
ARTL Quant Ranking